European Cystoscopes Market
- Report Code: CY 1002
- Publish Date: Upcoming
Cystoscopy is a medical procedure that is used to examine the insides of a bladder. This procedure is carried out using a thin, fiber optic tube called a cystoscope, which has a light and a camera at one end. The cystoscope is inserted into the urethra and moved up into the bladder, while the camera transmits images to a screen where they can be seen by a specialist. Cystoscopy is used to investigate and treat symptoms and conditions that affect the bladder and urinary system.
Europe accounts for a share of 26.58% of the cystoscopes device market globally, in 2013. The market value was valued at $93 million in 2012 that is expected to grow at a CAGR of 5.5% from 2013 to 2018. Cystoscopy is a minimally invasive test that is not very time-consuming. For instance, a cystoscopy of the bladder takes about 20 minutes to perform and for the most part is pain-free. These advantages are the main factors for the significant increase in the number of cystoscopy procedures performed, annually. In the U.K. alone, 341,000 cystoscopies are performed, yearly. The rising incidences of bladder cancer are likely to increase the demand for cystocopy procedures, which in turn is expected to propel the demand for urology endoscopes in Europe.
Some of the rigid cystoscopes available in the market are Olympus A2013 Rigid Cystoscope (Olympus Medical Systems Corporation), Stryker 502-427-030 Cystoscope (Stryker Corporation), Karl Storz Pediatric Cystoscopy Set (Karl Storz GmbH & Co. KG), and Pentax ECY-1570 (Pentax Medical System).
The report provides an extensive competitive landscaping of companies that operate in this market. Key players of the market covered in the report are Olympus Medical Systems Corporation, Karl Storz, Covidien Plc, Boston Scientific, Stryker Corporation, Fujifilm Holdings Corporation, and Pentax Medical System.
The report covers market segments that include Flexible Video Cystoscopes and Non-Video Cystoscopes. It also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities in the market. Details of the segment and country-specific shares (U.K., France, Germany, Spain, Italy), news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report.
Customization Options :
Along with the market data, you can also customize MMM assessments that meet your company’s specific requirements. You can customize your report to get a comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix that provides a detailed comparison of the product portfolios of each company that is mapped at the country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Procedure Volume Data
- Different types of cystoscopy procedures performed annually in Europe that have been tracked till the sub-segment level.
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Pricing Trends
- Cost analysis of cystoscope devices in Asia.
Competitive Intelligence
- A company share analysis of top players of the market in the region.
- Crucial developments and strategies of the top companies
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Rigid Endoscopes Market The North American Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $1.03billion in 2013 and expected to be $1.41 billion by 2018, growing at a CAGR of 6.5%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
European Rigid Endoscopes Market The European Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $0.66 billion in 2013 and expected to be $0.86 billion by 2018, growing at a CAGR of 5.4%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
Asian Rigid Endoscopes Market The Asian Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $0.61 billion in 2013 and expected to be $0.86 billion by 2018, growing at a CAGR of 7.2%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
